Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

PowerPoint Presentation

4,425 views

Published on

  • Be the first to comment

PowerPoint Presentation

  1. 1. Case History<br />66 year old man complains of:<br />Epigastric pain which has gradually increased for the past two months<br />Loss of appetite (anorexia)<br />Early satiety<br />Weight loss of 5 kilos<br />Vomited twice in the past week<br />
  2. 2. Case History <br />Black bowel movements for 2 days three weeks previously (melena) <br />Wakes at night with pain<br />Took aspirin for pain<br />Weak<br />
  3. 3. Objective Findings<br />Physical examination: <br />fullness and tenderness in the epigastrium<br />Lab<br />Hemoglobin 11.6 g/dl, MCV 68, Fe 26 (low)<br />
  4. 4. Doc – What’s wrong with me?(Have I got Cancer?)<br />
  5. 5. Clinical Approach<br />
  6. 6. Differential DiagnosisBenign Disease<br />Peptic Ulcer Disease<br />Gastritis, gastric ulcer, duodenitis, duodenal ulcer<br />Hepatobiliary disease<br />Gallstone disease<br />Pancreatic disease<br />Pancreatitis – acute, chronic, <br />
  7. 7. Differential DiagnosisMalignant Disease<br />Gastric tumor <br />Adenocarcinoma, lymphoma, Gastrointestinal Stromal Tumors (GIST), leiomyosarcoma, neuroendocrine <br />Liver and bile ducts<br />Primary, secondary liver tumors, cholangiocarcinoma, gallbladder cancer<br />Pancreas<br />Adenocarcinoma solid (>80%) or cystic (5%), neuroendocrine<br />
  8. 8. Alarm Symptoms<br />Age >50y<br />Increasing abdominal pain, <br />Wakes at night <br />Anorexia, Weight loss<br />Early satiety<br />Anemia<br />Conclusion: Urgent Investigation<br />
  9. 9. Gastric Tumors<br />5 main types: <br />Adenocarcinoma: This is the most common type of stomach cancer, 90 to 95 percent of stomach cancer cases, and develops in the glandular tissues. <br />Lymphoma: Develops in lymphatic tissue of the stomach wall – about 5% of tumors.<br />Carcinoid Tumors: Develops in the hormone-producing tissues of the stomach. Most of these tumors do not spread to other organs – 3%. <br />Gastrointestinal Stomal Tumors (GIST): Develops in the stomach wall tissues that contain a specific type of cell called intestinal cells of Cajal. Gastrointestinal stomal tumors are a rare form of cancer and can occur anywhere in the gastrointestinal tract. However the majority of GIST cases occur in stomach – 2%. <br />Leiomyosarcoma: Develops in the stomach muscle layer 1%.<br />
  10. 10. Epidemiology of Gastric Adenocarcinoma<br />
  11. 11. Gastric Carcinoma Epidemiology<br />
  12. 12. Gastric Adenocarcinoma-Epidemiology<br />Incidence and mortality decreasing<br />Risk greater in lower socioeconomic classes<br />Migrants from high to low-incidence nations maintain their susceptibility to gastric cancer<br />Migrant offspring approximates that of the new homeland<br />Environmental exposure early in life<br />Dietary carcinogens<br />
  13. 13. Pathogenesis of Gastric Cancer<br />Environmental<br />(intestinal type)<br />Helicobacter pylori<br />Diet <br />High concentrations of nitrates in dried, smoked, and salted foods<br />Smoking<br />Surgery to control benign peptic ulcer disease<br />Adenomatous polyps<br />Ménétrier's disease<br />Genetic<br />(diffuse type)<br />Familial adenomatouspolyposis (FAP) <br />Hereditary nonpolyposis colorectal cancer (HNPCC) <br />E-cadherin mutations, <br />IL1βpoymorphism<br />Blood group A<br />
  14. 14. Multistep Pathway in the Pathogenesis of Gastric Cancer <br />
  15. 15. Helicobacter and Gastric Cancer<br />36/1246H. pylori positive 0/280 negative patients developed gastric cancer<br />
  16. 16. Gastric Cancer - Diagnosis<br />Investigations<br />Barium studies<br />Upper gastrointestinal gastroscopy<br />CT scan<br />Endoscopic ultrasound (EUS)<br />Tumor markers - blood<br />
  17. 17. Normal Barium Study<br />Gastric fundus<br />Gastric body<br />Duodenal cap<br />Pylorus<br />Gastric antrum<br />Duodenum-2nd part<br />
  18. 18. Tumor<br />Gastric antrum<br />Barium Contrast Upper GI Series Gastric Cancer - Intestinal Type<br />
  19. 19. Gastric Cancer – Linitis Plastica<br />Tumor<br />Gastric antrum<br />
  20. 20. Accuracy of Upper GI Series<br />Concern about missing gastric cancer<br />Double-contrast upper GI studies - sensitivity of more than 95% <br />Anatomical shifting of cancer toward the proximal stomach<br />carcinomas of the cardia and fundus now comprise 30% to 40% <br />difficult to evaluate by barium studies<br />
  21. 21. Endoscopy<br />Procedure of choice<br />Sensitivity – 95% for advanced gastric cancer<br />Ability to take biopsies<br />Perform on any patient with dypepsia >45y<br />Perform on any patient with alarm symptoms<br />
  22. 22. Normal Gastroscopy<br />Gastric fundus<br />Gastric body<br />Pylorus<br />Gastric antrum<br />
  23. 23. Gastric Cancer<br />Lauren classification<br />Diffuse type 30 - 40% <br />Younger patients<br />Genetic mutations <br />“Linitis plastica"-type tumour<br />H. pylori not important<br />Intestinal type 60-70%<br />Older age, more men<br />Environmental causes<br />Discrete tumour <br />H.pylori important<br />
  24. 24. Pathology<br />Intestinal Type<br />Diffuse Type<br />
  25. 25. Signet Ring Cells<br />
  26. 26. CT<br />65% to 90% sensitivity for advanced gastric cancer<br />50% for early gastric cancers<br />CT has trouble discerning metastases less than 5 mm in size<br />CT is mainly for the detection of distant metastases and as a complement to EUS for assessing regional lymph node involvement<br />
  27. 27. Endoscopic UltrasoundStaging<br />Early vs advanced - 90% to 99% accurate<br />EUS is comparable to CT detecting perigastric nodes<br />accuracy ranging around 50% to 80%<br />
  28. 28. Clinical Stage-TNM System<br /> Tis: Carcinoma in situ: intraepithelial tumor without invasion of the lamina propriaT1: Tumor invades lamina propria or submucosaT2: Tumor invades the muscularis propria or the subserosaT3: Tumor penetrates the serosa (visceral peritoneum) without invading adjacent structuresT4: Tumor invades adjacent structures<br />
  29. 29. Staging: Nodes and Metastases (TNM)<br />Regional Lymph Nodes (N)<br />N0: No regional lymph node metastasis <br />N1: Metastasis in 1 to 6 regional lymph nodes <br />N2: Metastasis in 7 to 15 regional lymph nodes <br />N3: Metastasis in more than 15 regional lymph nodes<br />Distant metastasis (M)<br />MX: Distant metastasis cannot be assessed<br />M0: No distant metastasis<br />M1: Distant metastasis <br />
  30. 30. Treatment<br />Surgery – only hope of cure<br />Chemotherapy<br />Radiotherapy<br />
  31. 31. Gastric Cancer - Prognosis<br />1-5-year relative survival rates for gastrectomy patients<br />
  32. 32. Lymphoma<br />Malignancies of the lymphatic system<br />Hodgkin’s and Non-Hodgkin’s lymphoma (NHL)<br />GI lymphomas (Ly) are almost always NHL<br />GI tract may be involved as part of the general involvement or the only site (secondary or primary)<br />May be B cell (85%) or T-cell (15%)<br />
  33. 33. Gastric Lymphoma<br />Stomach can be the primary site <br />The stomach can be secondarily involved in disseminated nodal disease <br />20% of all gastric tumors<br />90% are B-cell Lymphomas<br />40% low grade mucosa-associated lymphoid tissue or MALT<br />50% diffuse large B-cell lymphoma<br />
  34. 34. Maltoma<br />Normal gastric tissue does not have lymphoid tissue<br />Chronic antigenic stimulation by H pylori may be the initiating event in the pathogenesis of gastric MALT lymphoma<br />H.pylori infection causes gastritis which leads to lymphoid aggregates, lymphoid hyperplasia, clonal expansion <br />
  35. 35. Clinical<br />Epigastric pain<br />Dypepsia<br />
  36. 36. Maltoma<br />
  37. 37. Low Grade MALToma Treatment<br />Early stage low grade and Helicobacter pylori positive – 95% of maltomas –eradication<br />60-80% respond<br />Complete regression may take >12 m<br />Endoscopic and EUS follow-up required<br />Advanced - chemotherapy<br />
  38. 38. Diffuse Large B-cell LymphomaClinical<br />Pain<br />Nausea<br />Vomiting<br />Anorexia, weight loss<br />Fever<br />Night sweats<br />Diarrhea<br />
  39. 39. Lymphoma - Upper GI series<br />Tumor<br />
  40. 40. Lymphoma - Gastroscopy<br />Gastric Lymphoma<br />Maltoma<br />
  41. 41. CT - Gastric Lymphoma<br />Low Grade Malt Lymphoma<br />High Grade Malt Lymphoma<br />
  42. 42. Diffuse Large B-cell Lymphoma Treatment <br />Chemotherapy<br />Radiotherapy<br />Surgery<br />
  43. 43. Carcinoid<br />Neuroendocrine tumors<br />Enterochromaffin cells (EC) of the gastrointestinal tract<br />Stain with potassium chromate (chromaffin), a feature of cells that contain serotonin<br />The clinical characteristics of carcinoid tumors vary with the location of the tumor <br />
  44. 44. Carcinoids of the GI Tract<br />Carcinoid malignancies originating from 3 areas: <br />Foregut<br />esophagus, stomach and the bronchial tree of the lungs; <br />Midgut<br />pancreas, duodenum, ilium and appendix; and <br />Hindgut<br />ascending, descending and transverse colons and rectum<br />
  45. 45. Gastric Carcinoid - Types<br />Type 1 - Hypergastrinemia <br />Pernicious anemia and chronic atrophic gastritis<br />usually multiple, small and benign, <br />Type 2 - Hypergastrinemia<br />multiple endocrine neoplasia type 1 (MEN1) combined with Zollinger-Ellison syndrome<br />Small, multiple and can metastasize<br />Type 3 No hypergastrinaemia<br />Highly malignant and metastasize<br />
  46. 46. Hypergastrinemia<br />Gastrin Causes ECL Hyperplasia<br />
  47. 47. Carcinoid<br />Average at diagnosis – 62y<br />Male = Female<br />Usually asymptomatic – incidental finding at gastroscopy<br />EUS helps define invasion<br />Biopsies stain for chromogranin<br />
  48. 48. Treatment <br />Type 1<br />Spontaneous resolution <br />Endoscopic polypectomy <br />Antrectomy <br />Total gastrectomy<br />Hydrochloric acid<br />Type 2/3<br />Surgery<br />
  49. 49. Gastric Carcinoid - Prognosis<br />

×